Quoin Pharmaceuticals Ltd...

0.22
-0.02 (-9.02%)
At close: Mar 31, 2025, 3:55 PM
0.23
2.68%
After-hours: Mar 31, 2025, 07:06 PM EDT
-9.02%
Bid 0.22
Market Cap 2M
Revenue (ttm) n/a
Net Income (ttm) -12.31M
EPS (ttm) -1.91
PE Ratio (ttm) -0.12
Forward PE -0.19
Analyst Buy
Ask 0.25
Volume 285,729
Avg. Volume (20D) 5,551,696
Open 0.24
Previous Close 0.24
Day's Range 0.22 - 0.24
52-Week Range 0.22 - 1.57
Beta 1.59

About QNRX

Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia....

Industry Biotechnology
Sector Healthcare
IPO Date Aug 1, 2016
Employees 3
Stock Exchange NASDAQ
Ticker Symbol QNRX
Full Company Profile

Analyst Forecast

According to 1 analyst ratings, the average rating for QNRX stock is "Buy." The 12-month stock price forecast is $4, which is an increase of 1686.51% from the latest price.

Stock Forecasts
1 month ago
+15.4%
Quoin Pharmaceuticals shares are trading higher af... Unlock content with Pro Subscription
3 months ago
+14.99%
Quoin Pharmaceuticals shares are trading higher after the company announced it received FDA clearance to initiate a new QRX003 Netherton Syndrome clinical study.